首页 > 最新文献

Geburtshilfe Und Frauenheilkunde最新文献

英文 中文
S2k-Guideline Non-hormonal Contraception, Part 1: Natural Family Planning, Lactational Amenorrhea, Barrier Methods, Coitus Interruptus: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015 - 095, January 2024). 非荷尔蒙避孕 S2k 准则,第 1 部分:自然计划生育、泌乳闭经、屏障法、性交中断:DGGG、OEGGG 和 SGGG 准则(S2k 级,AWMF 登记号 015 - 095,2024 年 1 月)。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-06 eCollection Date: 2024-08-01 DOI: 10.1055/a-2317-9133
Bettina Böttcher, Maria J Beckermann, Barbara Berger, Jann Frederik Cremers, Elisabeth DʼCosta, Petra Frank-Herrmann, Tanja Freundl-Schütt, Cornelia Friedrich, Sören Funck, Christine Gathmann, Maren Goeckenjan, Sabine Goette, Katharina Hancke, Christian Leiber-Caspers, Jana Maeffert, Gabriele Merki, Patricia Oppelt, Saira-Christine Renteria, Annette Richter-Unruh, Sebastian Daniel Schäfer, Anne-Rose Schardt, Nina Schernus, Claudia Schumann-Doermer, Helga Seyler, Christine Sieber, Barbara Sonntag, Gabriele Stöcker, Bettina Toth, Angela Tunkel, Lisa-Maria Wallwiener, Sabine Segerer

Aim This official guideline was published and coordinated by the DGGG, OEGGG and SGGG with the involvement of other medical societies. The aim was to provide a consensus-based overview of non-hormonal forms of contraception based on an evaluation of the relevant literature. The first part of these summarized statements and recommendations presents natural family planning methods such as lactational amenorrhea, barrier methods and coitus interruptus. The second part will focus on intrauterine devices and sterilization methods. Methods This S2k-guideline was developed by representative members from different medical professions on behalf of the guidelines commission of the DGGG, OEGGG and SGGG using a structured consensus process. Recommendations The guideline provides recommendations on the indications for, safety of use, benefits, and limitations of the different methods as well as recommendations on providing advice and other aspects of non-hormonal contraception. Natural family planning methods, lactational amenorrhea, barrier methods and coitus interruptus are discussed.

本官方指南由 DGGG、OEGGG 和 SGGG 共同发布和协调,其他医学协会也参与其中。其目的是在对相关文献进行评估的基础上,对非激素类避孕方式提供一个基于共识的概述。这些总结性声明和建议的第一部分介绍了自然计划生育方法,如哺乳期闭经、屏障避孕法和性交中断。第二部分将重点介绍宫内节育器和绝育方法。方法 这份 S2k 指导方针是由来自不同医学专业的代表成员代表 DGGG、OEGGG 和 SGGG 指导方针委员会,采用结构化共识程序制定的。建议 该指南就不同方法的适应症、使用安全性、益处和局限性提出了建议,并就非激素避孕的建议和其他方面提出了建议。其中还讨论了自然计划生育方法、哺乳期闭经、屏障避孕法和性交中断。
{"title":"S2k-Guideline Non-hormonal Contraception, Part 1: Natural Family Planning, Lactational Amenorrhea, Barrier Methods, Coitus Interruptus: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015 - 095, January 2024).","authors":"Bettina Böttcher, Maria J Beckermann, Barbara Berger, Jann Frederik Cremers, Elisabeth DʼCosta, Petra Frank-Herrmann, Tanja Freundl-Schütt, Cornelia Friedrich, Sören Funck, Christine Gathmann, Maren Goeckenjan, Sabine Goette, Katharina Hancke, Christian Leiber-Caspers, Jana Maeffert, Gabriele Merki, Patricia Oppelt, Saira-Christine Renteria, Annette Richter-Unruh, Sebastian Daniel Schäfer, Anne-Rose Schardt, Nina Schernus, Claudia Schumann-Doermer, Helga Seyler, Christine Sieber, Barbara Sonntag, Gabriele Stöcker, Bettina Toth, Angela Tunkel, Lisa-Maria Wallwiener, Sabine Segerer","doi":"10.1055/a-2317-9133","DOIUrl":"10.1055/a-2317-9133","url":null,"abstract":"<p><p><b>Aim</b> This official guideline was published and coordinated by the DGGG, OEGGG and SGGG with the involvement of other medical societies. The aim was to provide a consensus-based overview of non-hormonal forms of contraception based on an evaluation of the relevant literature. The first part of these summarized statements and recommendations presents natural family planning methods such as lactational amenorrhea, barrier methods and coitus interruptus. The second part will focus on intrauterine devices and sterilization methods. <b>Methods</b> This S2k-guideline was developed by representative members from different medical professions on behalf of the guidelines commission of the DGGG, OEGGG and SGGG using a structured consensus process. <b>Recommendations</b> The guideline provides recommendations on the indications for, safety of use, benefits, and limitations of the different methods as well as recommendations on providing advice and other aspects of non-hormonal contraception. Natural family planning methods, lactational amenorrhea, barrier methods and coitus interruptus are discussed.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 8","pages":"697-714"},"PeriodicalIF":2.4,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
S2k-Guideline Non-hormonal Contraception, Part 2: Intrauterine Devices and Sterilization: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015 - 095, January 2024). 非荷尔蒙避孕 S2k 准则,第 2 部分:宫内节育器和绝育:DGGG、OEGGG 和 SGGG 准则(S2k 级,AWMF 登记号 015 - 095,2024 年 1 月)。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-06 eCollection Date: 2024-08-01 DOI: 10.1055/a-2317-8993
Bettina Böttcher, Maria J Beckermann, Barbara Berger, Jann Frederik Cremers, Elisabeth DʼCosta, Petra Frank-Herrmann, Tanja Freundl-Schütt, Cornelia Friedrich, Sören Funck, Christine Gathmann, Maren Goeckenjan, Sabine Goette, Katharina Hancke, Christian Leiber-Caspers, Jana Maeffert, Gabriele Merki, Patricia Oppelt, Saira-Christine Renteria, Annette Richter-Unruh, Sebastian Daniel Schäfer, Anne-Rose Schardt, Nina Schernus, Claudia Schumann-Doermer, Helga Seyler, Christine Sieber, Barbara Sonntag, Gabriele Stöcker, Bettina Toth, Angela Tunkel, Lisa-Maria Wallwiener, Sabine Segerer

Aim This official guideline was published and coordinated by the DGGG, OEGGG and SGGG with the involvement of other medical societies. The aim was to provide a consensus-based overview of non-hormonal forms of contraception based on an evaluation of the relevant literature. The first part of these summarized statements and recommendations presents natural family planning methods such as lactational amenorrhea, barrier methods and coitus interruptus. The second part focuses on intrauterine devices and sterilization. Methods This S2k-guideline was developed by representative members from different medical professions on behalf of the guidelines commission of the DGGG, OEGGG and SGGG using a structured consensus process. Recommendations The guideline provides recommendations on the indications for, safety of use, benefits, and limitations of the different methods as well as recommendations on providing advice and other aspects of non-hormonal contraception. This summary presents recommendations and statements about intrauterine devices and female and male sterilization.

本官方指南由 DGGG、OEGGG 和 SGGG 共同发布和协调,其他医学协会也参与其中。其目的是在对相关文献进行评估的基础上,对非激素类避孕方式提供一个基于共识的概述。这些总结性声明和建议的第一部分介绍了自然计划生育方法,如哺乳期闭经、屏障法和性交中断。第二部分侧重于宫内节育器和绝育。方法 这份 S2k 指导方针是由来自不同医学专业的代表成员代表 DGGG、OEGGG 和 SGGG 指导方针委员会,采用结构化共识程序制定的。建议 该指南就不同方法的适应症、使用安全性、益处和局限性提出了建议,并就非激素避孕的建议和其他方面提出了建议。本摘要介绍了有关宫内节育器以及女性和男性绝育的建议和声明。
{"title":"S2k-Guideline Non-hormonal Contraception, Part 2: Intrauterine Devices and Sterilization: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015 - 095, January 2024).","authors":"Bettina Böttcher, Maria J Beckermann, Barbara Berger, Jann Frederik Cremers, Elisabeth DʼCosta, Petra Frank-Herrmann, Tanja Freundl-Schütt, Cornelia Friedrich, Sören Funck, Christine Gathmann, Maren Goeckenjan, Sabine Goette, Katharina Hancke, Christian Leiber-Caspers, Jana Maeffert, Gabriele Merki, Patricia Oppelt, Saira-Christine Renteria, Annette Richter-Unruh, Sebastian Daniel Schäfer, Anne-Rose Schardt, Nina Schernus, Claudia Schumann-Doermer, Helga Seyler, Christine Sieber, Barbara Sonntag, Gabriele Stöcker, Bettina Toth, Angela Tunkel, Lisa-Maria Wallwiener, Sabine Segerer","doi":"10.1055/a-2317-8993","DOIUrl":"10.1055/a-2317-8993","url":null,"abstract":"<p><p><b>Aim</b> This official guideline was published and coordinated by the DGGG, OEGGG and SGGG with the involvement of other medical societies. The aim was to provide a consensus-based overview of non-hormonal forms of contraception based on an evaluation of the relevant literature. The first part of these summarized statements and recommendations presents natural family planning methods such as lactational amenorrhea, barrier methods and coitus interruptus. The second part focuses on intrauterine devices and sterilization. <b>Methods</b> This S2k-guideline was developed by representative members from different medical professions on behalf of the guidelines commission of the DGGG, OEGGG and SGGG using a structured consensus process. <b>Recommendations</b> The guideline provides recommendations on the indications for, safety of use, benefits, and limitations of the different methods as well as recommendations on providing advice and other aspects of non-hormonal contraception. This summary presents recommendations and statements about intrauterine devices and female and male sterilization.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 8","pages":"715-736"},"PeriodicalIF":2.4,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing Severity and Need for Delivery in Early Onset Preeclampsia Before 32 Weeks of Gestation: a Delphi Consensus Procedure. 评估妊娠 32 周前早发子痫的严重程度和分娩需求:德尔菲共识程序。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-06 eCollection Date: 2024-08-01 DOI: 10.1055/a-2361-0563
Lars Brodowski, Maria Knoth, Leonie Zehner, Ulrich Pecks
<p><strong>Background: </strong>Preeclampsia is a potentially life-threatening hypertensive pregnancy disorder that carries an acute risk of an unfavorable outcome of the pregnancy but also has consequences for the long-term health of the mother. Women who develop the early form of pre-eclampsia before the 32nd week of pregnancy have the highest risk and are also the most difficult to treat. The severity of pre-eclampsia is not characterized uniformly in Germany, so that the indication for delivery is rather individualized. The aim of this study was to reach a consensus on parameters that could serve as criteria for describing the severity of pre-eclampsia based on the urgency of delivery. To this end, a Delphi procedure was used to present a scenario in which a woman was admitted for preeclampsia before 32 gestational weeks and after completion of antenatal steroid therapy.</p><p><strong>Methods: </strong>Clinicians specialized in maternal-fetal medicine from German-speaking countries completed five rounds of a modified Delphi questionnaire. Presented parameters were selected by the section "Hypertensive Pregnancy Diseases and Fetal Growth Restriction" of the German Society of Gynecology and Obstetrics after reviewing the literature. These included objectifiable laboratory or clinical parameters as well as subjective symptoms of the patient. In addition, nine fetal parameters were taken into account. The clinicians were asked to rate presented parameters as an indication for delivery on a Likert scale from 0 to 4 (no indication to absolute indication without delay). For each item, the predefined cut-off for group consensus was ≥ 70% agreement.</p><p><strong>Results: </strong>A total of 126 experts were approached. Sixty-nine experts (54.8%) took part in the first round; of those 50 completed the entire Delphi procedure. A consensus was reached on 14 parameters to be considered rapid preparation for delivery without delay (4 points on the Likert scale). These were among others hepatic hematoma or liver capsule rupture, acute liver failure with fulminant coagulation disorder or disseminated intravascular coagulation, eclampsia, pathologic findings in imaging (e.g. cMRI) or electrocardiogram arranged for new onset of headache or retrosternal pain, respectively. Twenty-six parameters were rated as factors that should be considered in the decision without being absolute (1 to 3 points), and 13 parameters should have no influence on the decision to deliver (0 points). No consensus on severe hypertension as an indication for delivery could be reached for blood pressure values below 220/140 mmHg.</p><p><strong>Conclusion: </strong>A consensus was reached on whether to deliver in preeclampsia typic clinical findings and symptoms. The results can serve as guidance for current clinical practice and for the definition of clinical endpoints in intervention studies. Nevertheless, the isolated criteria are a theoretical construction since the combined deterior
背景:先兆子痫是一种可能危及生命的妊娠高血压疾病,不仅有导致不利妊娠结局的急性风险,还会影响母亲的长期健康。在怀孕第 32 周之前患上早期先兆子痫的妇女风险最高,也最难治疗。先兆子痫的严重程度在德国并没有统一的标准,因此分娩指征的选择也是因人而异的。本研究的目的是根据分娩的紧迫性,就可作为子痫前期严重程度描述标准的参数达成共识。为此,研究人员采用德尔菲法(Delphi procedure),假设一名产妇在 32 孕周前、完成产前类固醇治疗后因先兆子痫入院:方法:来自德语国家的母胎医学专业临床医生完成了五轮改良德尔菲问卷调查。提出的参数由德国妇产科学会 "妊娠高血压疾病和胎儿生长受限 "分会在查阅文献后选定。这些参数包括客观的实验室或临床参数以及患者的主观症状。此外,还考虑了九项胎儿参数。临床医生被要求按照李克特量表从 0 到 4(从无指征到绝对指征,不得延误)对所提供的参数作为分娩指征进行评分。对于每个项目,小组共识的预定临界值为≥70%的一致性:结果:共联系了 126 位专家。69 名专家(54.8%)参加了第一轮讨论,其中 50 人完成了整个德尔菲程序。专家们就 14 项参数达成了共识,这些参数被认为是毫不延迟地为分娩做好快速准备(李克特量表 4 分)。这些参数包括肝血肿或肝囊破裂、急性肝功能衰竭并伴有暴发性凝血障碍或弥散性血管内凝血、子痫、影像学(如 cMRI)或心电图中的病理结果、新出现的头痛或胸骨后疼痛。26 项参数被评为在决定分娩时应考虑的因素,但并非绝对因素(1 至 3 分),13 项参数对分娩决定无影响(0 分)。对于血压值低于 220/140 mmHg 的重度高血压作为分娩指征的问题,未能达成共识:结论:对于子痫前期典型临床表现和症状是否需要分娩达成了共识。这些结果可以指导当前的临床实践和干预研究中临床终点的定义。然而,孤立的标准只是一种理论上的构建,因为多个因素的综合恶化或总和而非单一因素最有可能影响分娩的决定,并反映子痫前期的严重程度。此外,将高血压程度作为分娩指征仍存在争议,除非患者还伴有其他不适。未来的研究应将产妇的长期风险纳入决策辅助工具中。
{"title":"Assessing Severity and Need for Delivery in Early Onset Preeclampsia Before 32 Weeks of Gestation: a Delphi Consensus Procedure.","authors":"Lars Brodowski, Maria Knoth, Leonie Zehner, Ulrich Pecks","doi":"10.1055/a-2361-0563","DOIUrl":"10.1055/a-2361-0563","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Preeclampsia is a potentially life-threatening hypertensive pregnancy disorder that carries an acute risk of an unfavorable outcome of the pregnancy but also has consequences for the long-term health of the mother. Women who develop the early form of pre-eclampsia before the 32nd week of pregnancy have the highest risk and are also the most difficult to treat. The severity of pre-eclampsia is not characterized uniformly in Germany, so that the indication for delivery is rather individualized. The aim of this study was to reach a consensus on parameters that could serve as criteria for describing the severity of pre-eclampsia based on the urgency of delivery. To this end, a Delphi procedure was used to present a scenario in which a woman was admitted for preeclampsia before 32 gestational weeks and after completion of antenatal steroid therapy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Clinicians specialized in maternal-fetal medicine from German-speaking countries completed five rounds of a modified Delphi questionnaire. Presented parameters were selected by the section \"Hypertensive Pregnancy Diseases and Fetal Growth Restriction\" of the German Society of Gynecology and Obstetrics after reviewing the literature. These included objectifiable laboratory or clinical parameters as well as subjective symptoms of the patient. In addition, nine fetal parameters were taken into account. The clinicians were asked to rate presented parameters as an indication for delivery on a Likert scale from 0 to 4 (no indication to absolute indication without delay). For each item, the predefined cut-off for group consensus was ≥ 70% agreement.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 126 experts were approached. Sixty-nine experts (54.8%) took part in the first round; of those 50 completed the entire Delphi procedure. A consensus was reached on 14 parameters to be considered rapid preparation for delivery without delay (4 points on the Likert scale). These were among others hepatic hematoma or liver capsule rupture, acute liver failure with fulminant coagulation disorder or disseminated intravascular coagulation, eclampsia, pathologic findings in imaging (e.g. cMRI) or electrocardiogram arranged for new onset of headache or retrosternal pain, respectively. Twenty-six parameters were rated as factors that should be considered in the decision without being absolute (1 to 3 points), and 13 parameters should have no influence on the decision to deliver (0 points). No consensus on severe hypertension as an indication for delivery could be reached for blood pressure values below 220/140 mmHg.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;A consensus was reached on whether to deliver in preeclampsia typic clinical findings and symptoms. The results can serve as guidance for current clinical practice and for the definition of clinical endpoints in intervention studies. Nevertheless, the isolated criteria are a theoretical construction since the combined deterior","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 8","pages":"760-772"},"PeriodicalIF":2.4,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Hysteroscopy in the Assessment of Fallopian Tubal Patency: A Comprehensive Review and Meta-analysis. 宫腔镜在输卵管通畅性评估中的作用:全面回顾与元分析》。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-09 eCollection Date: 2024-07-01 DOI: 10.1055/a-2304-5018
Marlene Hager, Johannes Ott

Hysteroscopy has been recognized as a reliable method for the evaluation of female infertility for several years. The outpatient setting is particularly convenient, as patients do not require general anesthesia and do not have to stay overnight. In recent years, more and more articles have dealt with the role of diagnostic hysteroscopy in tubal evaluation. Twenty-four articles were included in this comprehensive review and 14 of them were also included in a meta-analysis. This review provides an overview of the different techniques of hysteroscopic tubal evaluation, with a focus on perioperative changes in cul-de-sac volume, the air bubble technique ("Parryscope" technique), the Flow technique and selective hysteroscopic pertubation with methylene blue dye (SHPMBD). In pooled analyses, SHPMBD achieved the highest sensitivity for tubal patency (91.7%, 95% confidence interval, CI: 88.8-94.0), whereas the air bubble technique revealed the highest specificity of all methods (98.4, 95% CI: 95.3-99.6). Furthermore, in a meta-analysis of all methods on the assessment of single tubes, an overall sensitivity of 87.1% and an overall specificity of 79.8% (95% CI: 76.4-82.9) could be shown. In conclusion, the techniques of hysteroscopic tubal evaluation are well-tolerated, clinically relevant, and reliable.

多年来,宫腔镜检查一直被认为是评估女性不孕症的可靠方法。门诊环境特别方便,因为患者不需要全身麻醉,也不必过夜。近年来,越来越多的文章探讨了诊断性宫腔镜在输卵管评估中的作用。本综述共收录了24篇文章,其中14篇还被纳入了荟萃分析。这篇综述概述了宫腔镜下输卵管评估的不同技术,重点关注内腔容积的围手术期变化、气泡技术("Parryscope "技术)、流式技术和亚甲蓝染料选择性宫腔镜穿刺术(SHPMBD)。在汇总分析中,SHPMBD 对输卵管通畅的敏感性最高(91.7%,95% 置信区间:88.8-94.0),而气泡技术的特异性在所有方法中最高(98.4,95% 置信区间:95.3-99.6)。此外,在对所有评估单侧输卵管的方法进行的荟萃分析中,结果显示总体敏感性为 87.1%,总体特异性为 79.8%(95% CI:76.4-82.9)。总之,宫腔镜输卵管评估技术具有良好的耐受性、临床相关性和可靠性。
{"title":"The Role of Hysteroscopy in the Assessment of Fallopian Tubal Patency: A Comprehensive Review and Meta-analysis.","authors":"Marlene Hager, Johannes Ott","doi":"10.1055/a-2304-5018","DOIUrl":"10.1055/a-2304-5018","url":null,"abstract":"<p><p>Hysteroscopy has been recognized as a reliable method for the evaluation of female infertility for several years. The outpatient setting is particularly convenient, as patients do not require general anesthesia and do not have to stay overnight. In recent years, more and more articles have dealt with the role of diagnostic hysteroscopy in tubal evaluation. Twenty-four articles were included in this comprehensive review and 14 of them were also included in a meta-analysis. This review provides an overview of the different techniques of hysteroscopic tubal evaluation, with a focus on perioperative changes in cul-de-sac volume, the air bubble technique (\"Parryscope\" technique), the Flow technique and selective hysteroscopic pertubation with methylene blue dye (SHPMBD). In pooled analyses, SHPMBD achieved the highest sensitivity for tubal patency (91.7%, 95% confidence interval, CI: 88.8-94.0), whereas the air bubble technique revealed the highest specificity of all methods (98.4, 95% CI: 95.3-99.6). Furthermore, in a meta-analysis of all methods on the assessment of single tubes, an overall sensitivity of 87.1% and an overall specificity of 79.8% (95% CI: 76.4-82.9) could be shown. In conclusion, the techniques of hysteroscopic tubal evaluation are well-tolerated, clinically relevant, and reliable.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 7","pages":"619-628"},"PeriodicalIF":2.4,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141590129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of the sFlt-1/PlGF Ratio in Certain Cohorts - What Needs to be Considered? 某些群体中 sFlt-1/PlGF 比率的意义--需要考虑哪些因素?
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-09 eCollection Date: 2024-07-01 DOI: 10.1055/a-2320-5843
Oliver Graupner, Stefan Verlohren, Tanja Groten, Dietmar Schlembach, Holger Stepan, Bettina Kuschel, Anne Karge, Ulrich Pecks

The sFlt-1/PlGF ratio is an established tool in clinical practice, where it is part of a diagnostic algorithm and informs the prognosis of preeclampsia (PE). Maternal and gestational comorbidities can affect the performance of the sFlt-1/PlGF ratio and its constituent elements, and a good understanding of the potential pitfalls is required. The objective of this paper was to provide a current narrative review of the literature on the diagnostic and predictive performance of the sFlt-1/PlGF ratio in specific patient cohorts. Potential factors which can negatively affect the clinical interpretability and applicability of the sFlt-1/PlGF ratio include chronic kidney disease, twin pregnancy, and maternal obesity. Pathophysiological mechanisms related to these factors and disorders can result in different concentrations of sFlt-1 and/or PlGF in maternal blood, meaning that the use of standard cut-off values in specific cohorts can lead to errors. To what extent the cut-off values should be adapted in certain patient cohorts can only be clarified in large prospective cohort studies. This applies to the use of the ratio both for diagnosis and prognosis.

在临床实践中,sFlt-1/PlGF 比值是一种成熟的工具,它是诊断算法的一部分,并为子痫前期(PE)的预后提供依据。母体和妊娠合并症会影响 sFlt-1/PlGF 比值及其组成要素的性能,因此需要充分了解潜在的误区。本文旨在对有关特定患者群中 sFlt-1/PlGF 比值的诊断和预测性能的文献进行叙述性综述。可能对 sFlt-1/PlGF 比值的临床可解释性和适用性产生负面影响的潜在因素包括慢性肾病、双胎妊娠和产妇肥胖。与这些因素和疾病相关的病理生理机制会导致母体血液中 sFlt-1 和/或 PlGF 的浓度不同,这意味着在特定人群中使用标准临界值可能会导致误差。只有在大型前瞻性队列研究中才能明确在特定患者队列中应在多大程度上调整临界值。这也适用于将比值用于诊断和预后。
{"title":"Significance of the sFlt-1/PlGF Ratio in Certain Cohorts - What Needs to be Considered?","authors":"Oliver Graupner, Stefan Verlohren, Tanja Groten, Dietmar Schlembach, Holger Stepan, Bettina Kuschel, Anne Karge, Ulrich Pecks","doi":"10.1055/a-2320-5843","DOIUrl":"10.1055/a-2320-5843","url":null,"abstract":"<p><p>The sFlt-1/PlGF ratio is an established tool in clinical practice, where it is part of a diagnostic algorithm and informs the prognosis of preeclampsia (PE). Maternal and gestational comorbidities can affect the performance of the sFlt-1/PlGF ratio and its constituent elements, and a good understanding of the potential pitfalls is required. The objective of this paper was to provide a current narrative review of the literature on the diagnostic and predictive performance of the sFlt-1/PlGF ratio in specific patient cohorts. Potential factors which can negatively affect the clinical interpretability and applicability of the sFlt-1/PlGF ratio include chronic kidney disease, twin pregnancy, and maternal obesity. Pathophysiological mechanisms related to these factors and disorders can result in different concentrations of sFlt-1 and/or PlGF in maternal blood, meaning that the use of standard cut-off values in specific cohorts can lead to errors. To what extent the cut-off values should be adapted in certain patient cohorts can only be clarified in large prospective cohort studies. This applies to the use of the ratio both for diagnosis and prognosis.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 7","pages":"629-634"},"PeriodicalIF":2.4,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Treatment of Patients with Endometriosis in the Certified Endometriosis Centers of the DACH Region - A Subanalysis of the Quality Assurance Study QS ENDO pilot. 达赫地区认证子宫内膜异位症中心对子宫内膜异位症患者的手术治疗--质量保证研究 QS ENDO 试点的子分析。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-09 eCollection Date: 2024-07-01 DOI: 10.1055/a-2324-3778
Felix Zeppernick, Magdalena Zeppernick, Monika Martina Wölfler, Elisabeth Janschek, Laura Holtmann, Sebastian Bornemann, Frank Oehmke, Darius Salehin, Chi Mi Scheible, Iris Brandes, Sigrid Vingerhagen-Pethick, Claus-Peter Cornelius, Alexander Boosz, Bernhard Krämer, Martin Sillem, Jörg Keckstein, Karl-Werner Schweppe, Ivo Meinhold-Heerlein

Introduction After puberty, at least 10% of all women and girls suffer from endometriosis. Surgery is useful for both the diagnosis and therapy. To date, quality indicators for the surgical treatment of endometriosis are lacking. QS ENDO aims to record the quality of care provided in the DACH region and to introduce quality indicators for the diagnosis and treatment of endometriosis. In the first phase of the study, QS ENDO real, the reality of care was recorded using a questionnaire. The second phase, QS ENDO pilot, investigated the treatment of patients who underwent surgery in certified endometriosis centers in a defined time-period. Material and Methods The surgical data of 10 patients from each of the 44 endometriosis centers in the DACH region was recorded using an online tool. Collected data included the approach used, the endometriosis phenotype, a description of the surgical site, resection status, histological confirmation, the use of a classification, and any complications. All operations were carried out in October 2016 as the defined time-period. The surgical approaches used were compared with the recommendations in the current guidelines. Results The data of 435 patients with a median age of 34 years were evaluated. 315 (72.4%) were nulliparous. 120 patients had given birth to at least one child and 42.5% (51) of them had delivered their child by caesarean section. About 50% of all patients also had deep infiltrating endometriosis in addition to ovarian endometriosis, and the median NAS score was 7.5. With regards to the surgical treatment, endometriomas were completely resected in 81% (94) of patients. 87.3% of patients underwent resection of peritoneal endometriosis. Forty-one patients had a hysterectomy, with a total hysterectomy carried out in 26 (63.4%) and a supracervical hysterectomy in 15 (36.6%) patients. Of the 59 patients with bowel endometriosis, half had segmental resection and half had shaving of the anterior rectal wall. Complications requiring revision occurred in 0.9% of cases. Conclusion The surgical procedures carried out in the certified endometriosis centers of the DACH region are largely in line with the recommendations for appropriate surgical approaches in the current standard guidelines.

导言:进入青春期后,至少有 10%的妇女和女孩患有子宫内膜异位症。手术对诊断和治疗都很有用。迄今为止,还缺乏子宫内膜异位症手术治疗的质量指标。QS ENDO旨在记录达赫地区的医疗质量,并引入子宫内膜异位症诊断和治疗的质量指标。在研究的第一阶段,即 QS ENDO 真实阶段,通过问卷调查记录了医疗服务的实际情况。第二阶段为 "QS ENDO 试点",调查了在规定时间段内,在经认证的子宫内膜异位症中心接受手术的患者的治疗情况。材料与方法 使用在线工具记录了来自达赫地区 44 家子宫内膜异位症中心各 10 名患者的手术数据。收集的数据包括使用的方法、子宫内膜异位症表型、手术部位描述、切除情况、组织学确认、分类的使用以及任何并发症。所有手术均以2016年10月为界定时间段。所使用的手术方法与现行指南的建议进行了比较。结果 评估了 435 名患者的数据,中位年龄为 34 岁。其中 315 人(72.4%)为无子宫。120名患者至少生育过一个孩子,其中42.5%(51人)通过剖腹产分娩。约50%的患者除卵巢子宫内膜异位症外,还患有深部浸润性子宫内膜异位症,NAS评分中位数为7.5分。在手术治疗方面,81%(94 例)的患者完全切除了子宫内膜异位症。87.3%的患者接受了腹膜子宫内膜异位症切除术。41 名患者接受了子宫切除术,其中 26 人(63.4%)接受了全子宫切除术,15 人(36.6%)接受了子宫颈上切除术。在59名患有肠道子宫内膜异位症的患者中,半数进行了节段切除,半数进行了直肠前壁刮除术。有 0.9% 的病例出现并发症,需要进行复查。结论 DACH地区经认证的子宫内膜异位症中心所采用的手术方法在很大程度上符合现行标准指南中关于适当手术方法的建议。
{"title":"Surgical Treatment of Patients with Endometriosis in the Certified Endometriosis Centers of the DACH Region - A Subanalysis of the Quality Assurance Study QS ENDO pilot.","authors":"Felix Zeppernick, Magdalena Zeppernick, Monika Martina Wölfler, Elisabeth Janschek, Laura Holtmann, Sebastian Bornemann, Frank Oehmke, Darius Salehin, Chi Mi Scheible, Iris Brandes, Sigrid Vingerhagen-Pethick, Claus-Peter Cornelius, Alexander Boosz, Bernhard Krämer, Martin Sillem, Jörg Keckstein, Karl-Werner Schweppe, Ivo Meinhold-Heerlein","doi":"10.1055/a-2324-3778","DOIUrl":"10.1055/a-2324-3778","url":null,"abstract":"<p><p><b>Introduction</b> After puberty, at least 10% of all women and girls suffer from endometriosis. Surgery is useful for both the diagnosis and therapy. To date, quality indicators for the surgical treatment of endometriosis are lacking. QS ENDO aims to record the quality of care provided in the DACH region and to introduce quality indicators for the diagnosis and treatment of endometriosis. In the first phase of the study, QS ENDO real, the reality of care was recorded using a questionnaire. The second phase, QS ENDO pilot, investigated the treatment of patients who underwent surgery in certified endometriosis centers in a defined time-period. <b>Material and Methods</b> The surgical data of 10 patients from each of the 44 endometriosis centers in the DACH region was recorded using an online tool. Collected data included the approach used, the endometriosis phenotype, a description of the surgical site, resection status, histological confirmation, the use of a classification, and any complications. All operations were carried out in October 2016 as the defined time-period. The surgical approaches used were compared with the recommendations in the current guidelines. <b>Results</b> The data of 435 patients with a median age of 34 years were evaluated. 315 (72.4%) were nulliparous. 120 patients had given birth to at least one child and 42.5% (51) of them had delivered their child by caesarean section. About 50% of all patients also had deep infiltrating endometriosis in addition to ovarian endometriosis, and the median NAS score was 7.5. With regards to the surgical treatment, endometriomas were completely resected in 81% (94) of patients. 87.3% of patients underwent resection of peritoneal endometriosis. Forty-one patients had a hysterectomy, with a total hysterectomy carried out in 26 (63.4%) and a supracervical hysterectomy in 15 (36.6%) patients. Of the 59 patients with bowel endometriosis, half had segmental resection and half had shaving of the anterior rectal wall. Complications requiring revision occurred in 0.9% of cases. <b>Conclusion</b> The surgical procedures carried out in the certified endometriosis centers of the DACH region are largely in line with the recommendations for appropriate surgical approaches in the current standard guidelines.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 7","pages":"646-655"},"PeriodicalIF":2.4,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141590128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Upper Abdominal Surgery Regarding the Outcome of Patients with Advanced Ovarian Cancer. 上腹手术对晚期卵巢癌患者预后的影响
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-04 eCollection Date: 2024-09-01 DOI: 10.1055/a-2331-0900
Maximilian Pietschmann, Anna Jaeger, Susanne Reuter, Barbara Schmalfeldt

Objective: Residual tumor after cytoreductive surgery is the most important prognostic parameter for the outcome of patients with advanced ovarian cancer (5-year survival rate FIGO III 39%, FIGO IV 20%). As more than half of the patients suffer from upper abdominal tumor burden, surgery in this area is inevitable in order to achieve adequate cytoreduction. Our analysis focuses on the impact of upper abdominal interventions (UAI) regarding residual tumor and prognosis (OS, PFS).

Methods: A total of n = 261 patients with advanced primary ovarian cancer stage FIGO III and IV and radical cytoreductive surgery at the Gynecologic Cancer Center Hamburg-Eppendorf between 2014 and 2019 were analyzed in a retrospective study design and divided into two groups: one with UAI (n = 160) and one without UAI (n = 101).

Results: Patients with UAI showed significantly more often a residual tumor of less than 1 cm (R1) than patients without UAI and had a significantly longer OS (59 vs. 45 months [p = 0.041]). Deperitonealization of the diaphragm was the most common (144/160) and prognostically most relevant procedure for UAI. Especially the subgroup with FIGO IIIC stage seemed to benefit most from UAI. However, in multivariate analysis residual tumor burden was the strongest prognostic parameter for survival, followed by FIGO stage and UAI. Mortality was low within in the UAI group (0.6%).

Conclusion: UAI is an essential part of cytoreductive surgery in advanced ovarian cancer patients with tumor spread into the upper abdomen as it significantly prolongs survival. The procedure appears to be safe with low mortality. Achieving R1 rather than R2 due to radical surgery combined with UAI should be preferred compared to the early termination of the operation, as this has a significant impact on the prognosis of the patients.

目的:细胞减灭术后肿瘤残留是晚期卵巢癌患者预后最重要的参数(5 年生存率 FIGO III 为 39%,FIGO IV 为 20%)。由于半数以上的患者存在上腹部肿瘤负担,因此为了达到充分的细胞减灭术,该部位的手术是不可避免的。我们的分析重点是上腹部介入手术(UAI)对残留肿瘤和预后(OS、PFS)的影响:方法:我们采用回顾性研究设计,分析了2014年至2019年期间在汉堡-埃彭多夫妇科癌症中心接受根治性细胞减灭术的FIGO III期和IV期晚期原发性卵巢癌患者,共261例,分为两组:一组有UAI(160例),另一组无UAI(101例):结果:UAI患者的残留肿瘤小于1厘米(R1)的比例明显高于无UAI患者,且OS明显更长(59个月对45个月[p = 0.041])。膈肌腹膜外切除术是最常见的 UAI 手术(144/160),也是与预后最相关的手术。尤其是 FIGO IIIC 分期的亚组似乎从 UAI 中获益最多。然而,在多变量分析中,残余肿瘤负荷是影响生存率的最强预后参数,其次是FIGO分期和UAI。UAI组的死亡率较低(0.6%):结论:对于肿瘤扩散到上腹部的晚期卵巢癌患者来说,UAI是细胞清除手术的重要组成部分,因为它能显著延长患者的生存期。该手术似乎很安全,死亡率很低。与提前终止手术相比,通过根治性手术联合 UAI 达到 R1 而不是 R2 更为可取,因为这对患者的预后有重大影响。
{"title":"The Impact of Upper Abdominal Surgery Regarding the Outcome of Patients with Advanced Ovarian Cancer.","authors":"Maximilian Pietschmann, Anna Jaeger, Susanne Reuter, Barbara Schmalfeldt","doi":"10.1055/a-2331-0900","DOIUrl":"10.1055/a-2331-0900","url":null,"abstract":"<p><strong>Objective: </strong>Residual tumor after cytoreductive surgery is the most important prognostic parameter for the outcome of patients with advanced ovarian cancer (5-year survival rate FIGO III 39%, FIGO IV 20%). As more than half of the patients suffer from upper abdominal tumor burden, surgery in this area is inevitable in order to achieve adequate cytoreduction. Our analysis focuses on the impact of upper abdominal interventions (UAI) regarding residual tumor and prognosis (OS, PFS).</p><p><strong>Methods: </strong>A total of n = 261 patients with advanced primary ovarian cancer stage FIGO III and IV and radical cytoreductive surgery at the Gynecologic Cancer Center Hamburg-Eppendorf between 2014 and 2019 were analyzed in a retrospective study design and divided into two groups: one with UAI (n = 160) and one without UAI (n = 101).</p><p><strong>Results: </strong>Patients with UAI showed significantly more often a residual tumor of less than 1 cm (R1) than patients without UAI and had a significantly longer OS (59 vs. 45 months [p = 0.041]). Deperitonealization of the diaphragm was the most common (144/160) and prognostically most relevant procedure for UAI. Especially the subgroup with FIGO IIIC stage seemed to benefit most from UAI. However, in multivariate analysis residual tumor burden was the strongest prognostic parameter for survival, followed by FIGO stage and UAI. Mortality was low within in the UAI group (0.6%).</p><p><strong>Conclusion: </strong>UAI is an essential part of cytoreductive surgery in advanced ovarian cancer patients with tumor spread into the upper abdomen as it significantly prolongs survival. The procedure appears to be safe with low mortality. Achieving R1 rather than R2 due to radical surgery combined with UAI should be preferred compared to the early termination of the operation, as this has a significant impact on the prognosis of the patients.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 9","pages":"866-875"},"PeriodicalIF":2.4,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Milk and Nurture: Breastfeeding's Powerful Impact on Breast Cancer. 超越乳汁和养育:母乳喂养对乳腺癌的强大影响。
IF 2.7 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-13 eCollection Date: 2024-06-01 DOI: 10.1055/a-2313-0637
Muhammad Mustafa, Sadaf Sarfraz, Gullelalah Saleem, Touqeer Ahmad Khan, Damiya Shahid, Saba Taj, Noor Amir

Breast cancer (BC) stands as a global concern, given its high incidence and impact on women's mortality. This complex disease has roots in various risk factors, some modifiable and others not. Understanding and identifying these factors can be instrumental in both preventing BC and improving survival rates. Remarkably, women's reproductive behaviors have emerged as critical determinants of BC susceptibility. Numerous studies have shed light on how aspects including age of menarche, first pregnancy and menopause along with number of pregnancies, hormone replacement therapies, can influence one's risk of developing BC. Furthermore, the act of breastfeeding and its duration have shown an inverse relationship with BC risk. This review delves into the biological and molecular mechanisms associated with breastfeeding that contribute to BC protection. It highlights the role of endocrine processes triggered by suckling stimulation, the gradual onset of lactational amenorrhea, delayed weaning, reduced lifetime menstrual cycles, chromosomal repair mechanisms, and immunological events throughout the lactation cycle. These insights provide a potential explanation for the protective effects conferred by breastfeeding against breast carcinomas.

鉴于乳腺癌(BC)的高发病率和对妇女死亡率的影响,它已成为全球关注的焦点。这种复杂的疾病源于各种风险因素,有些可以改变,有些则不能。了解和识别这些因素有助于预防乳腺癌和提高存活率。值得注意的是,女性的生殖行为已成为 BC 易感性的关键决定因素。大量研究揭示了包括月经初潮年龄、首次怀孕和更年期、怀孕次数、激素替代疗法等方面是如何影响女性罹患乳腺癌的风险的。此外,母乳喂养行为及其持续时间也与乳腺癌风险呈反比关系。本综述深入探讨了与母乳喂养相关的、有助于保护乳腺癌的生物和分子机制。它强调了哺乳刺激引发的内分泌过程、哺乳期闭经的逐渐发生、断奶延迟、终生月经周期减少、染色体修复机制以及整个哺乳周期中的免疫事件的作用。这些见解为母乳喂养对乳腺癌的保护作用提供了可能的解释。
{"title":"Beyond Milk and Nurture: Breastfeeding's Powerful Impact on Breast Cancer.","authors":"Muhammad Mustafa, Sadaf Sarfraz, Gullelalah Saleem, Touqeer Ahmad Khan, Damiya Shahid, Saba Taj, Noor Amir","doi":"10.1055/a-2313-0637","DOIUrl":"10.1055/a-2313-0637","url":null,"abstract":"<p><p>Breast cancer (BC) stands as a global concern, given its high incidence and impact on women's mortality. This complex disease has roots in various risk factors, some modifiable and others not. Understanding and identifying these factors can be instrumental in both preventing BC and improving survival rates. Remarkably, women's reproductive behaviors have emerged as critical determinants of BC susceptibility. Numerous studies have shed light on how aspects including age of menarche, first pregnancy and menopause along with number of pregnancies, hormone replacement therapies, can influence one's risk of developing BC. Furthermore, the act of breastfeeding and its duration have shown an inverse relationship with BC risk. This review delves into the biological and molecular mechanisms associated with breastfeeding that contribute to BC protection. It highlights the role of endocrine processes triggered by suckling stimulation, the gradual onset of lactational amenorrhea, delayed weaning, reduced lifetime menstrual cycles, chromosomal repair mechanisms, and immunological events throughout the lactation cycle. These insights provide a potential explanation for the protective effects conferred by breastfeeding against breast carcinomas.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 6","pages":"541-554"},"PeriodicalIF":2.7,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11175834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Reviews on the Prevention of Adverse Pregnancy Outcomes Related to Maternal Obesity to Improve Evidence-Based Counselling. 关于预防与孕产妇肥胖相关的不良妊娠结局的系统性综述,以改进循证咨询。
IF 2.7 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-13 eCollection Date: 2024-06-01 DOI: 10.1055/a-2295-1725
Susann Behnam, Birgit Arabin

Background: Health professionals and their patients should understand the importance of evidence. In the case of gestational diabetes mellitus, which is often associated with an abnormally high body mass index, the immediate and long-term outcome of women and their offspring depends in part on advice and implementation of lifestyle changes before, during and after pregnancy.

Methods: Up to September 2023, MEDLINE, CENTRAL, and WEB OF SCIENCE were used to identify systematic reviews and meta-analyses on the prevention of gestational diabetes. The ROBIS and AMSTAR criteria were analyzed for all systematic reviews.

Results: A total of 36 systematic reviews were identified. Dietary interventions, physical activity or a combined approach all reduced adverse pregnancy outcomes such as gestational diabetes, pregnancy-induced hypertension and related morbidities. Within the randomized controlled trials included in the 36 systematic reviews, the type, intensity and frequency of interventions varied widely. The primary outcomes, reporting and methodological quality of the 36 systematic reviews and meta-analyses also varied.The meta-analysis with the highest ROBIS and AMSTAR-2 scores was selected to design an icon array based on a fact box simulating 100 patients.

Conclusions: We propose a methodology for selecting the best evidence and transforming it into a format that illustrates the benefits and harms in a way that can be understood by lay patients, even if they cannot read. This model can be applied to counselling for expectant mothers in low and high-income countries, regardless of socioeconomic status, provided that women have access to appropriately trained healthcare providers.

背景:医疗专业人员及其患者应了解证据的重要性。就妊娠糖尿病而言,它通常与异常高的体重指数有关,妇女及其后代的近期和远期预后在一定程度上取决于孕前、孕期和产后改变生活方式的建议和实施:方法:利用截至 2023 年 9 月的 MEDLINE、CENTRAL 和 WEB OF SCIENCE 查找有关预防妊娠糖尿病的系统综述和荟萃分析。对所有系统综述的 ROBIS 和 AMSTAR 标准进行了分析:结果:共确定了 36 篇系统综述。饮食干预、体育锻炼或综合方法都能减少不良妊娠结局,如妊娠糖尿病、妊娠诱发高血压和相关疾病。在 36 篇系统综述所包含的随机对照试验中,干预的类型、强度和频率差异很大。我们选择了 ROBIS 和 AMSTAR-2 得分最高的荟萃分析,根据模拟 100 名患者的事实框设计了一个图标阵列:我们提出了一种方法,用于选择最佳证据,并将其转化为非专业患者(即使不识字)也能理解的形式,说明其益处和害处。这种模式可用于为低收入和高收入国家的孕妇提供咨询,无论其社会经济地位如何,前提是妇女能够获得经过适当培训的医疗服务提供者的服务。
{"title":"Systematic Reviews on the Prevention of Adverse Pregnancy Outcomes Related to Maternal Obesity to Improve Evidence-Based Counselling.","authors":"Susann Behnam, Birgit Arabin","doi":"10.1055/a-2295-1725","DOIUrl":"10.1055/a-2295-1725","url":null,"abstract":"<p><strong>Background: </strong>Health professionals and their patients should understand the importance of evidence. In the case of gestational diabetes mellitus, which is often associated with an abnormally high body mass index, the immediate and long-term outcome of women and their offspring depends in part on advice and implementation of lifestyle changes before, during and after pregnancy.</p><p><strong>Methods: </strong>Up to September 2023, MEDLINE, CENTRAL, and WEB OF SCIENCE were used to identify systematic reviews and meta-analyses on the prevention of gestational diabetes. The ROBIS and AMSTAR criteria were analyzed for all systematic reviews.</p><p><strong>Results: </strong>A total of 36 systematic reviews were identified. Dietary interventions, physical activity or a combined approach all reduced adverse pregnancy outcomes such as gestational diabetes, pregnancy-induced hypertension and related morbidities. Within the randomized controlled trials included in the 36 systematic reviews, the type, intensity and frequency of interventions varied widely. The primary outcomes, reporting and methodological quality of the 36 systematic reviews and meta-analyses also varied.The meta-analysis with the highest ROBIS and AMSTAR-2 scores was selected to design an icon array based on a fact box simulating 100 patients.</p><p><strong>Conclusions: </strong>We propose a methodology for selecting the best evidence and transforming it into a format that illustrates the benefits and harms in a way that can be understood by lay patients, even if they cannot read. This model can be applied to counselling for expectant mothers in low and high-income countries, regardless of socioeconomic status, provided that women have access to appropriately trained healthcare providers.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 6","pages":"564-572"},"PeriodicalIF":2.7,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11175830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Hallmarks of Endometriosis. 子宫内膜异位症的特征。
IF 2.7 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-13 eCollection Date: 2024-06-01 DOI: 10.1055/a-2306-8759
Iason Psilopatis, Stefanie Burghaus, Katharina Au, Louisa Hofbeck, Lisa Windischbauer, Laura Lotz, Matthias W Beckmann

A heuristic tool called "the hallmarks of cancer" helps to reduce the enormous complexity of cancer phenotypes and genotypes to a preliminary set of guiding principles. Other aspects of cancer have surfaced as possible improvements in our understanding of the disease's mechanisms. Endometriosis is a gynecological disease condition negatively impacting the quality of life of many women. To date, there is no curative treatment for endometriosis. Therapy is aimed at treating the symptoms using hormone therapy, pain therapy and complementary therapy. Chronic pain and overlapping pain syndromes and illnesses can also be treated with multimodal pain therapy and psychosomatic therapy. Endometriosis is, however, a chronic and complex entity which, in this regard, resembles cancer. The present work investigates the hallmarks of endometriosis with a view to summarizing the current research status and paving new ways for future research projects.

一种名为 "癌症标志 "的启发式工具有助于将癌症表型和基因型的巨大复杂性简化为一套初步的指导原则。癌症的其他方面也浮出水面,有可能增进我们对疾病机理的了解。子宫内膜异位症是一种妇科疾病,对许多妇女的生活质量造成了负面影响。迄今为止,还没有根治子宫内膜异位症的方法。治疗的目的是通过激素疗法、疼痛疗法和辅助疗法来治疗症状。慢性疼痛和重叠性疼痛综合征及疾病也可通过多模式疼痛疗法和心身疗法进行治疗。然而,子宫内膜异位症是一种慢性、复杂的疾病,在这方面与癌症相似。本著作对子宫内膜异位症的特征进行了研究,旨在总结目前的研究现状,并为未来的研究项目铺平新的道路。
{"title":"The Hallmarks of Endometriosis.","authors":"Iason Psilopatis, Stefanie Burghaus, Katharina Au, Louisa Hofbeck, Lisa Windischbauer, Laura Lotz, Matthias W Beckmann","doi":"10.1055/a-2306-8759","DOIUrl":"10.1055/a-2306-8759","url":null,"abstract":"<p><p>A heuristic tool called \"the hallmarks of cancer\" helps to reduce the enormous complexity of cancer phenotypes and genotypes to a preliminary set of guiding principles. Other aspects of cancer have surfaced as possible improvements in our understanding of the disease's mechanisms. Endometriosis is a gynecological disease condition negatively impacting the quality of life of many women. To date, there is no curative treatment for endometriosis. Therapy is aimed at treating the symptoms using hormone therapy, pain therapy and complementary therapy. Chronic pain and overlapping pain syndromes and illnesses can also be treated with multimodal pain therapy and psychosomatic therapy. Endometriosis is, however, a chronic and complex entity which, in this regard, resembles cancer. The present work investigates the hallmarks of endometriosis with a view to summarizing the current research status and paving new ways for future research projects.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 6","pages":"555-563"},"PeriodicalIF":2.7,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11175833/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Geburtshilfe Und Frauenheilkunde
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1